Welcome to our dedicated page for Churchill Capital X SEC filings (Ticker: CCCXU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Churchill Capital Corp X (CCCXU) provides direct access to the company’s regulatory disclosures as a Nasdaq-listed blank check company. Churchill X files reports with the U.S. Securities and Exchange Commission that describe its SPAC structure, unit composition, governance changes and its proposed business combination with ColdQuanta, Inc. (Infleqtion).
Key documents for CCCXU include Current Reports on Form 8-K that outline material events. For example, a Form 8-K dated July 2, 2025 details the commencement of separate trading for the units, Class A ordinary shares (CCCX) and warrants (CCCXW), including the warrant exercise terms. Another Form 8-K dated September 8, 2025 summarizes the Agreement and Plan of Merger and Reorganization with Infleqtion, the planned domestication from the Cayman Islands to Delaware, the intended name change to "Infleqtion, Inc." and the conditions required to close the Transactions.
Through this page, users can review Churchill X’s registration statement on Form S-4 and related proxy statement/prospectus once filed and declared effective. These filings explain the proposed issuance of securities in the business combination, shareholder voting matters, risk factors and detailed descriptions of Infleqtion’s business. Additional filings may include periodic reports and further 8-Ks documenting board changes, director compensation agreements and other governance matters.
Stock Titan enhances access to these filings with AI-powered tools that summarize lengthy documents, highlight key sections such as transaction structure, closing conditions and dilution mechanics, and help users quickly locate information on unit terms, warrant features and the domestication process. Investors can also use this page to monitor any future Forms 4 or other ownership-related filings that may be associated with Churchill X’s directors, officers or sponsor entities as they are reported to EDGAR in real time.
Barclays PLC filed an amended Schedule 13G reporting beneficial ownership of 1,797,424 shares of Churchill Capital Corp X-A common stock, representing 4.31% of the class as of December 31, 2025.
Barclays has sole voting and dispositive power over all reported shares, with no shared power. The firm states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Churchill Capital Corp X-A.
The filing also notes that Barclays’ ownership is 5 percent or less of the company’s common stock, and identifies Barclays Bank PLC and Barclays Capital Inc as relevant subsidiaries.
Churchill Capital Corp X (CCCX) has filed Amendment No. 2 to its Form S-4 to register up to 244,463,410 shares of common stock to be issued in connection with its proposed business combination with ColdQuanta, Inc. (d/b/a Infleqtion). CCCX will domesticate from the Cayman Islands to Delaware and, through a two-step merger, Infleqtion will become a wholly owned subsidiary and the combined public company will be renamed “Infleqtion, Inc.”
The merger values Infleqtion at an aggregate Equity Value of $1,800,000,000, paid entirely in stock at $10.00 per share, implying an estimated exchange ratio of about 0.347 new shares for each Infleqtion common share. A concurrent PIPE Investment will provide $126,547,600 of CCCX common stock at $10.00 per share. Pro forma ownership under no-redemption and maximum-redemption cases ranges from 214,924,762 to 173,524,762 shares outstanding, with Infleqtion holders owning the majority in both scenarios. CCCX’s board unanimously approved the deal, supported by a fairness opinion from Ocean Tomo, and is calling a shareholder meeting on February 12, 2026, while seeking to list the new Infleqtion, Inc. shares on the NYSE under the symbol “INFQ.”
Churchill Capital Corp X has filed an amended Form S-4 for its proposed business combination with quantum technology company ColdQuanta, Inc. (d/b/a Infleqtion). This proxy statement/prospectus covers up to 244,463,410 shares of common stock of the post-closing company to be issued in connection with the merger and related transactions.
The deal values Infleqtion at an equity value of $1.8 billion, to be paid entirely in post-closing common stock at $10.00 per share, with an estimated exchange ratio of about 0.347 post-closing shares for each Infleqtion common share. CCX has also arranged a $126,547,600 PIPE investment at $10.00 per share to help fund the transaction.
Following the deal, CCX will domesticate from the Cayman Islands to Delaware and be renamed Infleqtion, Inc. Pro forma, Infleqtion stockholders are expected to hold the majority of the combined company, with SPAC public holders, the sponsor and PIPE investors owning the balance under various redemption scenarios. The CCX board unanimously approved the merger and received a fairness opinion supporting the purchase price.
Churchill Capital Corp X reporting persons (Churchill Sponsor X LLC, M. Klein Associates, Inc. and Michael Klein) filed Amendment No. 1 to a Schedule 13D reporting beneficial ownership of 10,650,000 ordinary shares, representing 20.4% of the Class A ordinary shares (includes 300,000 Class A and 10,350,000 Class B convertible one-for-one on closing).
The amendment discloses a definitive Merger Agreement to combine Churchill with ColdQuanta, Inc. through a two-step merger and related Transactions, including a $126,547,600 PIPE at $10.00 per share. It also describes an Amended and Restated Registration Rights Agreement with specified resale registration timing, an Amended and Restated Sponsor Agreement with 1,500,000 sponsor shares that vest upon a $12 VWAP trigger or change of control, and an Advisory Agreement paying a $250,000 quarterly retainer to The Klein Group.
Churchill Capital Corp X entered into a definitive Merger Agreement with ColdQuanta, Inc. that contemplates Churchill's domestication from the Cayman Islands to Delaware and a name change to Infleqtion, Inc. Upon closing, existing Cayman Class A shares, warrants and units will convert into Domesticated SPAC common stock, warrants and adjusted options on a one-for-one or formulaic exchange basis. The transaction requires at least $100,000,000 of available SPAC cash at closing and is conditioned on customary approvals including special meetings of Churchill and ColdQuanta stockholder consent. A PIPE of $126,547,600 at $10.00 per share is committed to fund the closing. Sponsor shares include vesting tied to a VWAP trigger of $12.00 within specified periods or a qualifying change of control; failure to meet vesting within five years causes forfeiture. Registration rights for resale require filing within 30 business days post-closing and effectiveness no later than the 105th (or 165th) calendar day.
Sculptor Capital and related entities report beneficial ownership of 1,800,000 Class A ordinary shares of Churchill Capital Corp X, representing 4.32% of the Class A shares. The filing lists multiple reporting persons—Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc., Sculptor Master Fund, Ltd. and Sculptor Special Funding, LP—all of which indicate shared voting and dispositive power over 1,800,000 shares and no sole voting or dispositive power. The percentage base is 41,700,000 Class A shares per the issuer's Q-10 as of June 13, 2025.
Fort Baker Capital Management LP, Fort Baker Capital, LLC and Steven Patrick Pigott jointly report ownership of 2,650,000 Units of Churchill Capital Corp X/Cayman (CUSIP G2130T124), representing 6.4% of the Class A ordinary shares underlying Units based on 41,700,000 outstanding shares as of June 13, 2025. Each Unit consists of one Class A ordinary share and one-quarter of a redeemable warrant; the warrants are not currently exercisable and will not be exercisable within 60 days. The reporting persons state the securities were acquired and are held in the ordinary course of business and disclaim acting as a group. Signatures on the joint filing agreement are dated August 14, 2025.
Barclays PLC reports beneficial ownership of 2,730,528 units of Churchill Capital Corp X, representing 6.54% of the unit class. The filing shows Barclays holds sole voting and sole dispositive power over these units and identifies Barclays Bank PLC as the relevant subsidiary. The statement was filed on a Schedule 13G, and Barclays certifies the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
MMCAP International Inc. SPC and MM Asset Management Inc. report beneficial ownership of 2,000,000 Class A ordinary shares of Churchill Capital Corp X, representing 4.8% of the class. The reporting persons state they have shared voting power and shared dispositive power over these shares and no sole voting or dispositive power.
The filing is an amended Schedule 13G indicating passive investor status: the filers certify the shares were not acquired to change or influence control of the issuer. The report notes ownership is 5% or less of the class, so it does not reflect a control position.
Churchill Capital Corp X director reports no share ownership. Stephen Anthony Murphy, a director of Churchill Capital Corp X/Cayman, filed an initial ownership report stating that he does not beneficially own any non-derivative or derivative securities of the company. The filing is made on Form 3, which is used when an insider first becomes subject to reporting requirements. Both the non-derivative and derivative tables are empty, and the explanation of responses clearly notes that no securities are beneficially owned.